Clinical Trial

Genetic Determinants of Exercise-Induced Muscle Damage (POLYGENDOMUS)

Study acronym: POLYGENDOMUS
Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to evaluate the association between the evolution of plasma CPK levels and genetic polymorphisms, both before the muscle-damaging exercise and at three post-exercise time points. The investigators aim to include 300 participants in this research.
Trial Details
NCT Number NCT06740136
Lead Sponsor Lille University
Conditions Healthy
Enrollment 300 participants
Start Date 2023-03-13
Primary Completion 2024-06-28 (estimated)
Study Completion 2025-12-19 (estimated)
Updated on ClinicalTrials.gov 2024-12-18